[HTML][HTML] One-year incidences of venous thromboembolism, bleeding, and death in patients with lung cancer (Cancer-VTE Subanalysis)

N Awano, T Okano, R Kawachi, M Matsumoto… - JTO clinical and …, 2022 - Elsevier
Introduction This subanalysis aimed to provide real-world data on venous thromboembolism
(VTE) from patients with lung cancer in the Cancer-VTE Registry. Methods The primary …

One-Year Incidences of Venous Thromboembolism, Bleeding, and Death in Patients With Lung Cancer (Cancer-VTE Subanalysis)

N Awano, T Okano, R Kawachi… - JTO clinical and …, 2022 - pubmed.ncbi.nlm.nih.gov
Introduction This subanalysis aimed to provide real-world data on venous thromboembolism
(VTE) from patients with lung cancer in the Cancer-VTE Registry. Methods The primary …

[HTML][HTML] One-Year Incidences of Venous Thromboembolism, Bleeding, and Death in Patients With Lung Cancer (Cancer-VTE Subanalysis)

N Awano, T Okano, R Kawachi, M Matsumoto… - JTO Clinical and …, 2022 - jtocrr.org
Introduction This subanalysis aimed to provide real-world data on venous thromboembolism
(VTE) from patients with lung cancer in the Cancer-VTE Registry. Methods The primary …

One-Year Incidences of Venous Thromboembolism, Bleeding, and Death in Patients With Lung Cancer (Cancer-VTE Subanalysis).

N Awano, T Okano, R Kawachi… - JTO Clinical and …, 2022 - europepmc.org
Methods The primary outcome was the number of baseline VTE events in patients with lung
cancer. The 1-year cumulative incidences of symptomatic VTE; composite VTE (symptomatic …

[HTML][HTML] One-Year Incidences of Venous Thromboembolism, Bleeding, and Death in Patients With Lung Cancer (Cancer-VTE Subanalysis)

N Awano, T Okano, R Kawachi… - JTO Clinical and …, 2022 - ncbi.nlm.nih.gov
Methods The primary outcome was the number of baseline VTE events in patients with lung
cancer. The 1-year cumulative incidences of symptomatic VTE; composite VTE (symptomatic …